„Luteolin offers novel therapeutic regimen in rotenone-induced Parkinson disease via modulation of TNF-α/FXMRP/serotonin/tyrosine hydroxylase signaling pathway” (2026) Nigerian Journal of Physiological Sciences, 40(2). doi:10.54548/.